A-dmDT390-bisFv(UCHT1) immunotoxin

· Angimmune LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A-dmDT390-bisFv(UCHT1) immunotoxin, covering 2016-11-29 to 2016-11-29. Get the full timeline:

Most recent: Clinical Trial Update: A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) [Phase 2]